Remove 2021 Remove Collaboration Remove Patient Advocacy
article thumbnail

Patients Look Beyond the Pandemic to Pharma for Engagement, Innovation, and Integrity

Health Populi

Compared with a year ago, more patients and their advocates are seeking quality therapies, innovation, engagement, and integrity from pharmaceutical companies, based on research published today from PatientView. Together, these patient groups represented about 19 million patients’ perspectives for 2021.

article thumbnail

The Economics of the Pandemic Put Costs at the Top of Americans’ Health Reform Priorities

Health Populi

In 2021, patients-as-health-consumers seek lower health care and prescription drug costs coupled with higher quality care, discovered by the patient advocacy coalition, Consumers for Quality Care. A major side-effect of the coronavirus pandemic in 2020 was its impact on the national U.S.

Insurance 127
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Economics of the Pandemic Put Costs at the Top of Americans’ Health Reform Priorities

Health Populi

In 2021, patients-as-health-consumers seek lower health care and prescription drug costs coupled with higher quality care, discovered by the patient advocacy coalition, Consumers for Quality Care. A major side-effect of the coronavirus pandemic in 2020 was its impact on the national U.S.

article thumbnail

Top Physicians and Clinicians to Follow in Digital Health

Doximity

She's an active voice for patient advocacy and possesses a fervent passion for writing and speaking. Prior to this, she served diligently as a Doximity TeleHealth Fellow from November 2021 to January 2023. Follow her on Twitter , Facebook , TikTok , and Instagram.

Hospice 52
article thumbnail

In 2023, the U.S. Will Still Be the #1 Prescription Drug Spender in the World, IQVIA Forecasts

Health Populi

The rate of growth of Rx spending looks fairly flat from 2019 to 2023, the second bar chart illustrates, with net growth of spending just over 4% by 2021-2023. Other key trends to expect leading to 2023 will be: The rise of patient advocacy roles in pharma companies. China will have spent just over one-fourth of what the U.S.